| 发明名称 |
(E)-3-[1-n-Butyl-5-[2-(2-carboxyphenyl)methoxy-4-chlorophenyl]-1H-pyrazol-4-yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl]-prop-2-enoic acid monoargininyl salt |
| 摘要 |
This invention relates to a new monoargininyl salt form of the endothelin receptor antagonist (E)-3-[1-n-Butyl-5-[2-(2-carboxyphenyl)methoxy-4-chlorophenyl]-1H-pyrazol-4-yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl]-prop-2-enoic acid.
|
| 申请公布号 |
US6300359(B1) |
申请公布日期 |
2001.10.09 |
| 申请号 |
US20000581066 |
申请日期 |
2000.06.08 |
| 申请人 |
SMITHKLINE BEECHAM CORPORATION |
发明人 |
FLISAK JOSEPH ROBERT;KEARNEY ALBERT STEPHEN;PALEPU NAGESH;PERNG CHERNG-YIH |
| 分类号 |
A61K31/4155;A61P3/10;A61P9/00;A61P9/10;A61P9/12;A61P11/00;A61P13/06;A61P13/12;A61P43/00;C07D405/06;(IPC1-7):A61K31/415 |
主分类号 |
A61K31/4155 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
